phenanthridone has been researched along with Colorectal Neoplasms in 1 studies
phenanthridone: coal tar derivative; structure given in first source
phenanthridone : A member of the class of phenanthridines that is phenanthridine with an oxo substituent at position 6. A poly(ADP-ribose) polymerase (PARP) inhibitor, it has been shown to exhibit immunosuppressive activity.
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, QF | 1 |
| Gao, TT | 1 |
| Shi, YJ | 1 |
| Lei, Q | 1 |
| Liu, ZH | 1 |
| Feng, Q | 1 |
| Chen, ZJ | 1 |
| Yu, LT | 1 |
1 other study available for phenanthridone and Colorectal Neoplasms
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel 1-phenyl phenanthridin-6(5H)-one derivatives as anti-tumor agents targeting TOPK.
Topics: Animals; Antineoplastic Agents; Apoptosis; Colorectal Neoplasms; Heterografts; Humans; Mice; Mitogen | 2019 |